Identification, synthesis and quantification of process-related impurities in auraptene

Journal of Pharmaceutical and Biomedical Analysis

Volumn 56, Issue 2, 2011, Pages 191-199

  Li, Yan Gang ^a   Chen, Hai Fang ^a   Tu, Ming Zhu ^a   Zhang, Pu Zhao ^a   Wang, Xiao Yun ^a   Yuan, Jin Bin ^a   Yang, Wu Liang ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Auraptene; Identification; Impurity; Quantification; Synthesis

Indexed keywords

4 METHYLAURAPTENE; 6,7 DIHYDROXY 3,7 DIMETHYL 2 OCTEN UMBELLIFERONE; 6,7 EPOXY 3,7 DIMETHYL 2 OCTEN UMBELLIFERONE; AURAPTENE; PROTON; SODIUM ION; UMBELLIFERONE; UMBELLIFERONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG IMPURITY; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; MOLECULAR WEIGHT; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION STUDY;

CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, REVERSE-PHASE; COUMARINS; DRUG COMPOUNDING; DRUG CONTAMINATION; GUIDELINES AS TOPIC; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, INFRARED; TANDEM MASS SPECTROMETRY; TECHNOLOGY, PHARMACEUTICAL;

EID: 79960058643     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.05.011     Document Type: Article

References (9)

1. Nagao K., Yamano N., Shirouchi B., Inoue N., Murakami S., Sasaki T., Yanagita T. J. Agric. Food. Chem. 2010, 58:9028-9032.
2. Epifano F., Genovese S., Curini M. Auraptene: phytochemical and pharmacological properties. Phytochemistry Research Progress 2008, 145-162. Nova Biomedical Books. T. Matsumoto (Ed.).
3. Krishnan P., Yan K.J., Windler D., Tubbs J., Grand R., Li B.D., Aldaz C.M., McLarty J., Kleiner-Hancock H.E. BMC Cancer 2009, 29. p. 259.
4. Hayashi K., Suzuki R., Miyamoto S., Shin-Ichiroh Y., Kohno H., Sugie S., Takashima S., Tanaka T. Nutr. Cancer 2007, 58:75-84.
5. Curin M., Carvotto G., Epifano F., Giannone G. Curr. Med. Chem. 2006, 13:199-222.
6. Zhang P., Li Y., Tu M., Zhang Y., Chen H., Yang W. Lishizhen Med. Mater. Med. Res. 2010, 21:1851-1853.
7. ICH Harmonised Tripartite Guideline, Impurities in New Drug Substances, Q3A (R2), Current Step 4 version, 25 October 2006.
8. Pilaniya K., Chandrawanshi H.K., Pilaniya U., Manchandani P., Jain P., Singh N. J. Adv. Pharm. Technol. Res. 2010, 1:302-310.
9. Li Y., Zhang P., Chen H., Wang F., Wei L., Tu M., Yang W. J. Jiangxi Univ. TCM 2009, 21:43-45.